Comparable stake leader
BlackRock, Inc.
SEC ownership of DYNAVAX TECHNOLOGIES CORP
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001029142.
Disclosed value leader
BlackRock, Inc.
Comparable rows
8/20
Latest evidence
31 Mar 2026
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BlackRock, Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
8 of 20
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Mar 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001029142
- Issuer location
- Emeryville, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of DYNAVAX TECHNOLOGIES CORP (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
8/20
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 14%
12 rows are not safely comparable across share classes.
13D/G row: BlackRock, Inc.
Showing 1-8 of 20 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 14%.
8 of 20 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
14%
Kynam Capital Management, LP
5%
Francis Cano
0.04%
Elaine D. Sun
0.03%
Brent MacGregor
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 20 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
|
14%
|
$168,738,357
17,009,915 shares
|
$0 | 30 Jun 2025 |
| Kynam Capital Management, LP |
13D/G
|
5%
|
$71,513,102
6,560,835 shares
|
$0 | 31 Dec 2024 |
| Francis Cano |
3/4/5
Director
|
0.04%
|
$414,684
42,663 shares
|
— | 10 Feb 2026 |
| Elaine D. Sun |
3/4/5
Director
|
0.03%
|
$290,287
29,865 shares
|
— | 10 Feb 2026 |
| Brent MacGregor |
3/4/5
Director
|
0.02%
|
$212,177
21,829 shares
|
— | 10 Feb 2026 |
| Emilio Emini |
3/4/5
Director
|
0.01%
|
$97,929
10,075 shares
|
— | 10 Feb 2026 |
| Lauren P. Silvernail |
3/4/5
Director
|
0.01%
|
$97,929
10,075 shares
|
— | 10 Feb 2026 |
| IFP Advisors, Inc |
13F
Company
|
0%
|
$93
6 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$24,558,142.
Buys
$41,116
Insiders: 1
Sells
$24,599,258
Insiders: 2
Net
-$24,558,142
Shares: -2,205,337
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 3,800
Shares: 2,209,137
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 144,000 | $0 | $2,247,660 | -$2,247,660 |
| 9-12 | 3,800 | 2,065,137 | $41,116 | $22,351,598 | -$22,310,482 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 20 reporting-owner rows connected to DYNAVAX TECHNOLOGIES CORP. Open a relationship link for the CIK-to-CIK filing trail.
Rows
20
Largest Forms 3/4/5 holder
Andrew A. F. Hack
Net 12M change
-$24,558,142
Latest report
10 Feb 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Andrew A. F. Hack | Director | $13,885,710 | Mixed | 08 Aug 2023 | ||
| Robert Janssen | SVP and CMO | $1,752,854 | Mixed | 18 Feb 2025 | ||
| Ryan Spencer | CEO and Director, Director | $1,422,300 | Mixed | 10 Feb 2026 | ||
| David F. Novack | President & COO | $574,096 | -$2,247,660 | -80% | Mixed | 10 Feb 2026 |
| Peggy Phillips V | Director | $498,928 | Mixed | 23 May 2024 | ||
| John L. Slebir | SVP General Counsel | $430,996 | Mixed | 10 Feb 2026 | ||
| Francis Cano | Director | $414,684 | Mixed | 10 Feb 2026 | ||
| Kelly MacDonald | SVP and CFO | $400,222 | Mixed | 10 Feb 2026 | ||
| Justin Burgess | VP Finance & CAO | $335,802 | Mixed | 10 Feb 2025 | ||
| Elaine D. Sun | Director | $290,287 | Mixed | 10 Feb 2026 | ||
| Peter R. Paradiso | Director | $241,337 | Mixed | 11 Jun 2025 | ||
| Brent MacGregor | Director | $212,177 | Mixed | 10 Feb 2026 | ||
| Julia Marie Eastland | Director | $183,049 | Mixed | 23 May 2024 | ||
| Lauren P. Silvernail | Director | $97,929 | Mixed | 10 Feb 2026 | ||
| Emilio Emini | Director | $97,929 | Mixed | 10 Feb 2026 | ||
| Natale S. Ricciardi | Director | $68,516 | Mixed | 26 May 2022 | ||
| Deep Track Biotechnology Master Fund, Ltd. | 10%+ Owner | $0 | -$22,351,598 | -100% | Mixed | 10 Feb 2026 |
| Joseph Anthony Metzinger | VP, Chief Accounting Officer | $0 | Mixed | 10 Feb 2026 | ||
| Scott Dunseth Myers | Director | $0 | +$41,116 | Mixed | 10 Feb 2026 | |
| Daniel L. Kisner | Director | $0 | Mixed | 10 Feb 2026 |
Recent insider transactions for DYNAVAX TECHNOLOGIES CORP
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Deep Track Biotechnology Master Fund, Ltd. | DVAX | Common Stock, par value $0.001 per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -15,726,349 | 0 | 10 Feb 2026 | Direct | ||
| Ryan Spencer | DVAX | Common Stock - Performance Stock Units | Disposed to Issuer | -100% | -301,000 | 0 | 10 Feb 2026 | Direct | ||
| Ryan Spencer | DVAX | Common Stock - Performance Stock Units | Award | 301,000 | 165,000 | 10 Feb 2026 | Direct | |||
| Ryan Spencer | DVAX | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -379,620 | 0 | 10 Feb 2026 | Direct | ||
| Ryan Spencer | DVAX | Restricted Stock Units | Disposed to Issuer | -100% | -145,667 | 0 | 10 Feb 2026 | Direct | ||
| Ryan Spencer | DVAX | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -1,916,000 | 0 | 10 Feb 2026 | Direct | ||
| John L. Slebir | DVAX | Common Stock - Performance Stock Units | Disposed to Issuer | -100% | -92,424 | 0 | 10 Feb 2026 | Direct | ||
| John L. Slebir | DVAX | Common Stock - Performance Stock Units | Award | 92,424 | 50,000 | 10 Feb 2026 | Direct | |||
| John L. Slebir | DVAX | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -69,634 | 0 | 10 Feb 2026 | Direct | ||
| John L. Slebir | DVAX | Restricted Stock Units | Disposed to Issuer | -100% | -44,949 | 0 | 10 Feb 2026 | Direct | ||
| John L. Slebir | DVAX | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -608,000 | 0 | 10 Feb 2026 | Direct | ||
| Joseph Anthony Metzinger | DVAX | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -7,129 | 0 | 10 Feb 2026 | Direct | ||
| Joseph Anthony Metzinger | DVAX | Restricted Stock Units | Disposed to Issuer | -100% | -25,455 | 0 | 10 Feb 2026 | Direct | ||
| Joseph Anthony Metzinger | DVAX | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -31,500 | 0 | 10 Feb 2026 | Direct | ||
| Kelly MacDonald | DVAX | Common Stock - Performance Stock Units | Disposed to Issuer | -100% | -88,854 | 0 | 10 Feb 2026 | Direct | ||
| Kelly MacDonald | DVAX | Common Stock - Performance Stock Units | Award | 88,854 | 46,430 | 10 Feb 2026 | Direct | |||
| Kelly MacDonald | DVAX | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -60,204 | 0 | 10 Feb 2026 | Direct | ||
| Kelly MacDonald | DVAX | Restricted Stock Units | Disposed to Issuer | -100% | -43,759 | 0 | 10 Feb 2026 | Direct | ||
| Kelly MacDonald | DVAX | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -675,500 | 0 | 10 Feb 2026 | Direct | ||
| Emilio Emini | DVAX | Common Stock - Restricted Stock Units | Disposed to Issuer | -100% | -10,075 | 0 | 10 Feb 2026 | Direct | ||
| Emilio Emini | DVAX | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -49,875 | 0 | 10 Feb 2026 | Direct | ||
| Scott Dunseth Myers | DVAX | Common Stock - Restricted Stock Units | Disposed to Issuer | -100% | -31,204 | 0 | 10 Feb 2026 | Direct | ||
| Scott Dunseth Myers | DVAX | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -3,800 | 0 | 10 Feb 2026 | Direct | ||
| Scott Dunseth Myers | DVAX | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -135,375 | 0 | 10 Feb 2026 | Direct | ||
| Elaine D. Sun | DVAX | Common Stock - Restricted Stock Units | Disposed to Issuer | -100% | -29,865 | 0 | 10 Feb 2026 | Direct | ||
| Elaine D. Sun | DVAX | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -129,750 | 0 | 10 Feb 2026 | Direct | ||
| Daniel L. Kisner | DVAX | Common Stock - Restricted Stock Units | Disposed to Issuer | -100% | -21,829 | 0 | 10 Feb 2026 | Direct | ||
| Daniel L. Kisner | DVAX | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -1,500 | 0 | 10 Feb 2026 | Direct | ||
| Daniel L. Kisner | DVAX | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -146,000 | 0 | 10 Feb 2026 | Direct | ||
| Daniel L. Kisner | DVAX | Stock Option (Right o Buy) | Disposed to Issuer | -100% | -15,000 | 0 | 10 Feb 2026 | Direct | ||
| Brent MacGregor | DVAX | Common Stock - Restricted Stock Units | Disposed to Issuer | -100% | -21,829 | 0 | 10 Feb 2026 | Direct | ||
| Brent MacGregor | DVAX | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -171,000 | 0 | 10 Feb 2026 | Direct | ||
| Lauren P. Silvernail | DVAX | Common Stock - Restricted Stock Units | Disposed to Issuer | -100% | -10,075 | 0 | 10 Feb 2026 | Direct | ||
| Lauren P. Silvernail | DVAX | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -49,875 | 0 | 10 Feb 2026 | Direct | ||
| Francis Cano | DVAX | Common Stock - Restricted Stock Units | Disposed to Issuer | -100% | -42,663 | 0 | 10 Feb 2026 | Direct | ||
| Francis Cano | DVAX | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -146,000 | 0 | 10 Feb 2026 | Direct | ||
| David F. Novack | DVAX | Common Stock - Performance Stock Units | Disposed to Issuer | -100% | -124,224 | 0 | 10 Feb 2026 | Direct | ||
| David F. Novack | DVAX | Common Stock - Performance Stock Units | Award | 124,224 | 67,860 | 10 Feb 2026 | Direct | |||
| David F. Novack | DVAX | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -63,334 | 0 | 10 Feb 2026 | Direct | ||
| David F. Novack | DVAX | Restricted Stock Units | Disposed to Issuer | -100% | -60,196 | 0 | 10 Feb 2026 | Direct | ||
| David F. Novack | DVAX | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -788,000 | 0 | 10 Feb 2026 | Direct | ||
| David F. Novack | DVAX | Common Stock | Sale | -64.3% | $1,782,960 | $15.64 | -114,000 | 63,344 | 15 Jan 2026 | Direct |
| David F. Novack | DVAX | Common Stock | Options Exercise | 180% | 114,000 | 177,344 | 15 Jan 2026 | Direct | ||
| David F. Novack | DVAX | Stock Option (Right to Buy) | Options Exercise | -100% | -114,000 | 0 | 15 Jan 2026 | Direct | ||
| Kelly MacDonald | DVAX | Common Stock | Tax liability | -37.5% | -36,141 | 60,204 | 24 Dec 2025 | Direct | ||
| Joseph Anthony Metzinger | DVAX | Common Stock | Tax liability | -44% | -5,598 | 7,129 | 24 Dec 2025 | Direct | ||
| David F. Novack | DVAX | Common Stock | Tax liability | -43.2% | -48,107 | 63,344 | 24 Dec 2025 | Direct | ||
| David F. Novack | DVAX | Common Stock | Sale | -21.2% | $464,700 | $15.49 | -30,000 | 111,451 | 24 Dec 2025 | Direct |
| David F. Novack | DVAX | Common Stock | Options Exercise | 26.9% | 30,000 | 141,451 | 24 Dec 2025 | Direct | ||
| David F. Novack | DVAX | Stock Option (Right to Buy) | Options Exercise | -25.9% | -30,000 | 85,655 | 24 Dec 2025 | Direct |
* marks a reported price that did not pass the local price check.